11 unchanged sentences
Unregistered Sales of Equity Securities
−Removed: Equity Plan-Related Issuances
−Removed: From January 1, 2024 through June 30, 2024, we granted certain directors, officers, employees, consultants and other service providers options to purchase an aggregate of (i) 1,796,797 shares of our common stock under our 2021 Stock Plan (the 2021 Plan”) at exercise prices ranging from $8.84 to $13.32 per share, (ii) 1,880,680 shares of our common stock under our 2024 Performance Option Plan (the “2024 POP”) at an exercise price of $10.19 per share and (iii) 163,131 shares of our common stock under our 2024 Equity Incentive Plan (the “2024 EIP”) at an exercise price of $16.00 per share.
−Removed: Redeemable Convertible Preferred Stock Issuances
−Removed: In May 2024, we sold an aggregate of 41,264,892 shares of our Series C redeemable convertible preferred stock at a purchase price of $3.13826 per share.
−Removed: The aggregate purchase price for the Series C redeemable convertible preferred shares was $129,499,960.
−Removed: Concurrent Private Placement
−Removed: In connection with our IPO, we completed a concurrent private placement that closed on July 17, 2024, in which we issued and sold 2,500,000 shares of common stock at $16.00 per share, the IPO price, to AyurMaya Capital Management Fund, LP, an existing investor (the “Concurrent Private Placement”).
−Removed: This transaction did not involve any underwriters, underwriting discounts or commissions, or any public offering.
−Removed: The offers, sales and issuances of the securities described in the preceding paragraphs were deemed to be exempt from registration under the Securities Act in reliance on Section 4(a)(2) of the Securities Act or Rule 506 of Regulation D promulgated thereunder as a transaction by an issuer not involving a public offering.
−Removed: The recipients of securities in each of these transactions acquired the securities for investment only and not with a view to or for sale in connection with any
−Removed: distribution thereof.
−Removed: Each of the recipients of securities in these transactions was either an accredited investor within the meaning of Rule 501 of Regulation D under the Securities Act or had adequate access, through employment, business or other relationships, to information about us.
−Removed: Appropriate legends were affixed to the securities issued in these transactions.
−Removed: Use of Proceeds from our Initial Public Offering of Common Stock and Concurrent Private Placement
−Removed: On June 27, 2024, our Registration Statement on Form S-1, as amended (File No.
−Removed: 333-280068) (the “Registration Statement”), was declared effective in connection with our IPO, pursuant to which we sold an aggregate of 13,125,000 shares of our common stock at a price to the public of $16.00 per share.
−Removed: Morgan Stanley & Co.
−Removed: LLC, Leerink Partners LLC, Cantor Fitzgerald & Co.
−Removed: and Guggenheim Securities, LLC acted as joint book-running managers.
−Removed: The IPO closed on July 1, 2024.
−Removed: The aggregate net proceeds from the IPO were $193.3 million, after deducting underwriting discounts and commissions and other offering costs of $16.7 million.
−Removed: The offering terminated after the sale of all securities registered pursuant to the Registration Statement.
−Removed: No payments for such expenses were made directly or indirectly to (i) any of our officers or directors or their associates, (ii) any persons owning 10% or more of any class of our equity securities or (iii) any of our affiliates.
−Removed: In connection with the IPO, we completed the Concurrent Private Placement that closed on July 17, 2024, in which we issued and sold 2,500,000 shares of common stock at $16.00 per share, the IPO price, to AyurMaya Capital Management Fund, LP, an existing investor.
−Removed: The net proceeds from our IPO and Concurrent Private Placement have been invested according to our approved investment policy in a mix of money market funds and high-quality, available-for-sale marketable securities.
−Removed: There has been no material change in the planned use of proceeds from our IPO as described in the Company’s final prospectus for its IPO filed pursuant to Rule 424(b)(4) under the Securities Act with the SEC on June 28, 2024.
+Added: Since January 1, 2025, we have not issued any unregistered securities.
+Added: Purchases of Equity Securities by Issuers and Affiliated Purchasers
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.